日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Immune-mediated adverse events and overall survival with tremelimumab plus durvalumab and durvalumab monotherapy in unresectable HCC: HIMALAYA phase III randomized clinical trial

不可切除肝细胞癌患者接受 tremelimumab 联合 durvalumab 治疗和 durvalumab 单药治疗的免疫介导不良事件和总生存期:HIMALAYA III 期随机临床试验

Lau, George; Sangro, Bruno; Cheng, Ann-Lii; Kudo, Masatoshi; Kelley, Robin Kate; Tak, Won Young; Gasbarrini, Antonio; Reig, Maria; Lim, Ho Yeong; Tougeron, David; De Toni, Enrico N; Tam, Vincent C; Mody, Kabir; Gong, Jun; Crysler, Oxana V; Sukeepaisarnjaroen, Wattana; Lipatov, Oleg; Morimoto, Manabu; Archambeaud, Isabelle; Burgio, Valentina; Phuong, Le Thi Tuyet; Chao, Yee; Peron, Jean-Marie; Berres, Marie-Luise; Ko, Yoo-Joung; Ran, Di; Makowsky, Mallory; Negro, Alejandra; Abou-Alfa, Ghassan K

Implementation of practices shapes the effectiveness of agricultural diversification for arthropod related ecosystem services: a meta-analysis

实践的实施影响农业多样化对节肢动物相关生态系统服务的有效性:一项荟萃分析

Seimandi-Corda, Gaëtan; MacLaren, Chloe; Tougeron, Kevin; Forkman, Johannes; Hood, Jess; Mead, Andrew; Dixon, Amelia; Cook, Samantha M

Impact of next-generation sequencing on routine clinical practice and patient inclusion in molecularly targeted clinical trials: a retrospective cohort analysis

下一代测序对常规临床实践和分子靶向临床试验患者纳入的影响:一项回顾性队列分析

Faigner, Mathieu; Karayan-Tapon, Lucie; Cortes, Ulrich; Ndiaye, Birama; Martel, Marine; Rivet, Pierre; Duche, Jade; Isambert, Nicolas; Tougeron, David; Evrard, Camille

Analysis of diagnostic pathway and therapeutic delay for patients with pancreatic adenocarcinoma: a French retrospective study

胰腺腺癌患者诊断路径和治疗延误分析:一项法国回顾性研究

Evrard, Camille; Vauchel, Bérénice; Boyer, Claire; Ferru, Aurélie; Olivier, Raphael; Tougeron, David

Early ctDNA and Survival in Metastatic Colorectal Cancer Treated With Immune Checkpoint Inhibitors: A Secondary Analysis of the SAMCO-PRODIGE 54 Randomized Clinical Trial

早期ctDNA与接受免疫检查点抑制剂治疗的转移性结直肠癌患者的生存率:SAMCO-PRODIGE 54随机临床试验的二次分析

Taïeb, Julien; Sullo, Francesco Giulio; Lecanu, Aurélie; Bourreau, Camille; Barbier, Emilie; Gandini, Annalice; Bez, Jérémie; Mulot, Claire; Di Fiore, Frederic; Elhajbi, Farid; Borg, Christophe; Bouché, Olivier; Aparicio, Thomas; Zaanan, Aziz; André, Thierry; Tougeron, David; Taly, Valerie; Laurent-Puig, Pierre

Early treatment discontinuation in patients with deficient mismatch repair or microsatellite instability high metastatic colorectal cancer receiving immune checkpoint inhibitors

对于错配修复缺陷或微卫星不稳定性高、转移性结直肠癌且正在接受免疫检查点抑制剂治疗的患者,应尽早停止治疗。

Taieb, Julien; Ambrosini, Margherita; Alouani, Emily; Lonardi, Sara; Sinicrope, Frank A; Decraecker, Marie; Boileve, Alice; Hafliger, Emilie; Mazard, Thibault; Pernot, Simon; Parent, Pauline; Ros, Javier; Overman, Michael J; Jayachandran, Priya; Nasca, Vincenzo; Salvatore, Lisa; Guimbaud, Rosine; Cremolini, Chiara; Tougeron, David; Pietrantonio, Filippo

Efficacy of immunotherapy in gastrointestinal (GI) tumors with mismatch repair deficient (MMRd) unusual phenotype: an AGEO real-world study

免疫疗法治疗错配修复缺陷(MMRd)异常表型胃肠道肿瘤的疗效:一项AGEO真实世界研究

Alouani, Emily; Taieb, Julien; Tougeron, David; Roces, Guillaume; Hollebecque, Antoine; Parent, Pauline; Pernot, Simon; Sinicrope, Frank A; Hautefeuille, Vincent; Ben-Abdelghani, Meher; Dutherage, Marie; Cohen, Romain; Hafliger, Emilie; Sclafani, Francesco; Muller, Marie; Perkins, Géraldine; Masson, Thérèse; Aparicio, Thomas; Coutzac, Clélia; Mazard, Thibault; Decraecker, Marie; Jaffrelot, Marion; Guimbaud, Rosine; Selves, Janick

Sex and outcomes of patients with microsatellite instability-high and BRAF V600E mutated metastatic colorectal cancer receiving immune checkpoint inhibitors

性别与接受免疫检查点抑制剂治疗的微卫星不稳定性高和BRAF V600E突变转移性结直肠癌患者的预后

Nasca, Vincenzo; Zhao, Joseph; Ros, Javier; Lonardi, Sara; Zwart, Koen; Cohen, Romain; Fakih, Marwan; Jayachandran, Priya; Roodhart, Jeanine M L; Derksen, Jeroen; Intini, Rossana; Bergamo, Francesca; Mazzoli, Giacomo; Ghelardi, Filippo; Ligero, Marta; Jonnagaddala, Jitendra; Hawkins, Nicholas; Ward, Robyn L; Wankhede, Durgesh; Brenner, Hermann; Hoffmeister, Michael; Vitellaro, Marco; Salvatore, Lisa; Gallois, Claire; Laurent-Puig, Pierre; Cremolini, Chiara; Overman, Michael J; Taieb, Julien; Tougeron, David; Andre, Thierry; Kather, Jakob Nikolas; Sundar, Raghav; Carmona, Javier; Elez, Elena; Koopman, Miriam; Pietrantonio, Filippo

Interplay between sarcopenia, GDF-15, and the efficacy of nivolumab plus ipilimumab in patients with mismatch repair deficient metastatic colorectal cancer: final survival analysis of the phase II GERCOR NIPICOL study.

肌少症、GDF-15 与 nivolumab 加 ipilimumab 治疗错配修复缺陷型转移性结直肠癌患者的疗效之间的相互作用:II 期 GERCOR NIPICOL 研究的最终生存分析

Depotte Leonard, Nay Paula, Borg Christophe, Meurisse Aurélia, Henriques Julie, Bennouna Jaafar, De La Fouchardière Christelle, Tougeron David, Mazard Thibault, Chibaudel Benoist, Tournigand Christophe, Vernerey Dewi, Pigneur Frédéric, Andre Thierry, Cohen Romain

Clinical description and development of a prognostic score for neurofibromatosis type 1 (NF1)-associated GISTs: a retrospective study from the NETSARC

神经纤维瘤病1型(NF1)相关胃肠道间质瘤(GIST)的临床描述及预后评分的建立:一项来自NETSARC的回顾性研究

Cuvelier, C; Brahmi, M; Sobhani, I; Verret, B; Grancher, A; Penel, N; Toulmonde, M; Lahlou, W; Dupuis, H; Calavas, L; Muller, M; Watson, S; Bruyat, D; Poumeaud, F; Chaigneau, L; Manfredi, S; Lecomte, T; Bertucci, F; Ghiringhelli, F; Pracht, M; Mourthadhoi, F; Monceau-Baroux, L; Helyon, M; Kurtz, J-E; Roquin, G; Regenet, N; Vinches, M; Tougeron, D; Wolkenstein, P; Blay, J Y; Bouche, O; Hautefeuille, V